Glaxosmithkline Pharmaceuticals Ltd Nine Monthly Results

Gross Sales

2,774.84

2,523.91

2,464.27

2,468.4

2,181.17

Excise Duty

0

0

0

0

0

Net Sales

2,774.84

2,523.91

2,464.27

2,468.4

2,181.17

Other Operating Income

0

0

0

0

0

Other Income

109.94

110.06

76.05

97.26

141.18

Total Income

2,884.78

2,633.97

2,540.32

2,565.66

2,322.35

Total Expenditure

1,930.67

2,035.79

1,841.09

1,899.66

1,793.31

PBIDT

954.11

598.18

699.23

666

529.04

Interest

0.73

1.03

1.16

1.72

2.9

PBDT

953.38

597.15

698.07

664.28

526.14

Depreciation

52.07

51.58

48.59

52.84

60.92

Minority Interest Before NP

0

0

0

0

0

Tax

235.81

175.92

189.83

147.73

124.65

Deferred Tax

0.79

-25.83

-17.61

-11.96

-3.25

Reported Profit After Tax

664.71

395.48

477.26

475.67

343.82

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

664.71

395.48

477.26

475.67

343.82

Extra-ordinary Items

3.46

-98.93

-4.98

17.69

-37.1

Adjusted Profit After Extra-ordinary item

661.25

494.41

482.24

457.98

380.92

EPS (Unit Curr.)

39

23.35

28.17

30.46

23.85

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

240

320

0

0

0

Equity

169.41

169.41

169.41

169.41

169.41

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

34.38

23.7

28.37

26.98

24.25

PBDTM(%)

34.35

23.65

28.32

26.91

24.12

PATM(%)

23.95

15.66

19.36

19.27

15.76